As of 2025-05-08, the Intrinsic Value of Easton Pharmaceuticals Inc (EAPH) is -0.00 USD. This EAPH valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Easton Pharmaceuticals Inc is -92,249.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, Easton Pharmaceuticals Inc (EAPH) is overvalued by 92,249.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.00 - -0.00 | -0.00 | -92,249.00% |
| DDM - Stable | (0.00) - (0.00) | (0.00) | -173981.0% |
| DDM - Multi | (0.00) - (0.00) | (0.00) | -179.9% |
| Market Cap (mil) | 0.00 |
| Beta | -23.71 |
| Outstanding shares (mil) | 933.00 |
| Enterprise Value (mil) | 0.00 |
| Market risk premium | 4.60% |
| Cost of Equity | 1,288.12% |
| Cost of Debt | 5.00% |
| WACC | 4.15% |